Vivos Therapeutics, Inc Claimed Company

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is an innovative medical technology company focused on the development and commercialization of screening and treatment for obstructive sleep apnea (OSA). Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method. Combining technologies and protocols that alter the size, shape, and position of the tissues of the upper airway, the Vivos Method opens airway space and can significantly reduce or even eliminate the symptoms and conditions associated with mild to moderate OSA. read more

EMPLOYEE PARTICIPANTS: 4

TOTAL RATINGS: 30

CEO: R. Kirk Huntsman

HR or Marketing? Claim Your Free Employer Account

Diversity at Vivos Therapeutics, Inc

The Diversity score provides insights into how diverse employees feel and rate their work experience at Vivos Therapeutics, Inc across various culture dimensions.

Diversity and Inclusion at Vivos Therapeutics, Inc

Vivos Therapeutics’ mission is to rid the world of obstructive sleep apnea (OSA). We recognize that OSA doesn’t just affect one race, gender, age, religion, gender identity, sexual orientation, physical or mental ability, and perspective. Our company is committed to building a workforce that reflects that diversity. We want to build a company where everyone feels empowered to bring their full, authentic selves to work and we know that diverse teams are better teams.

Edit